Skip to main content
Echo

Category / Daily archive

Science news — November 11, 2026

Science publications published on November 11, 2026 (UTC). This is a fixed calendar-day archive.

5 publications

  1. ScienceGrid

    Poland's Orlen Cancels Qatar LNG Contract Over Disruptions

    Polish energy group Orlen has terminated a long-term contract for the supply of liquefied natural gas (LNG) with QatarEnergy due to the latter's inability to deliver shipments, citing force majeure conditions. The contract, signed in 2026, was set to provide annual supplies of one million tons of LNG until 2034. The decision comes amidst global supply disruptions, including Iranian attacks on Qatari gas facilities and the closure of the Strait of Hormuz.
    15 sourcesSee all sources
  2. ScienceSci Policy

    Deepinder Goyal's Temple Wearable Faces Scrutiny Over Brain Blood-Flow Claims

    Billionaire Deepinder Goyal's new wearable device, Temple, claims to monitor brain health and aging by measuring cerebral blood flow. However, the device's medical claims have been questioned by critics and doctors due to preliminary evidence and concerns over the validity of its core metric, the Brain Flow index. Goyal maintains that Temple is a fitness and AI device, not a medical diagnostic tool.
    7 sourcesSee all sources
  4. ScienceSoftwareSemiconductorsPhysics

    Google Launches Gemini 4 Carbon, Its Most Powerful AI Model Yet

    Google has globally launched its latest AI model, Gemini 4 Carbon, described as its strongest to date. The model targets complex, long-horizon agentic AI workflows and supports software engineering, full-stack development, and scientific research. It's available through Google AI Studio and Android Studio, with API access via Google's paid tier. Google AI Ultra subscribers can also access Carbon through AI Studio and Antigravity. The launch comes with promotional pricing starting at $2 per million input tokens.
    5 sourcesSee all sources
  5. ScienceUnited KingdomSpaceChemistry

    Russian Scientists Develop Artificial Liver

    Russian researchers have created an artificial liver using the patient's own cells, aiming to reduce organ transplant rejection. The device, developed by 'Artsellen' and MONIKA, can take over liver functions like toxin removal and protein synthesis while patients wait for a donor or recovery. Successful animal tests have been conducted, with human trials planned for 2027 and serial production starting in 2028 at 'TechnoPark Moscow'.
    3 sourcesSee all sources